Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

December 30, 2028

Study Completion Date

March 20, 2029

Conditions
Ovarian Epithelial Cancer
Interventions
PROCEDURE

Delayed interval cytoreductive surgery (DICS)

"patients will receive six courses of intravenous carboplatin and paclitaxel every 3 weeks, followed by delayed interval cytoreductive surgery (DICS) within 6 weeks of the last cycle of chemotherapy. After DICS, patients will be assessed for the need or not for further adjuvant chemotherapy.~chemotherapy regimen:~* Paclitaxel at 175 mg/m² + carboplatin area under the curve (AUC) 5-6 every 3 weeks.~* Paclitaxel at 60 mg/m² (days 1, 8, and 15), and carboplatin AUC 2 (days 1, 8, and 15) every 3 weeks.~* Paclitaxel at dense dose 80 mg/m² (days 1, 8, and 15) and carboplatin AUC 5-6 (day 1) every 3 weeks."

PROCEDURE

Early interval cytoreductive surgery (EICS)

"patients will receive three courses of intravenous carboplatin and paclitaxel every 3 weeks, followed by early interval cytoreductive surgery (EICS) within 6 weeks of the last cycle of chemotherapy. After EICS, patients will receive adjuvant three courses of intravenous carboplatin and paclitaxel every 3 weeks, then will be assessed for the need or not for further adjuvant chemotherapy.~chemotherapy regimen:~* Paclitaxel at 175 mg/m² + carboplatin area under the curve (AUC) 5-6 every 3 weeks.~* Paclitaxel at 60 mg/m² (days 1, 8, and 15), and carboplatin AUC 2 (days 1, 8, and 15) every 3 weeks.~* Paclitaxel at dense dose 80 mg/m² (days 1, 8, and 15) and carboplatin AUC 5-6 (day 1) every 3 weeks."

Trial Locations (1)

Unknown

RECRUITING

Elshatby Maternity University Hospital, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER